Human Genome (HGSI) volatility decreases into GlaxoSmithKline’s July 20 expiration of tender
Tweet Send to a FriendGet Alerts HGSI Hot Sheet
Trade HGSI Now!
Human Genome (Nasdaq: HGSI) overall option implied volatility of 44 is below its 26-week average of 74 into GlaxoSmithKline (NYSE: GSK) setting July 20 for the $13/sh tender offer for the company.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- From Novel Research to Innovative Medicines: GlaxoSmithKline Launches Discovery Fast Track Competition for Academic Researchers
- Sony (SNE) is Early Winner in Battle of Video Game Giants (MSFT)
- Amid Tesla (TSLA) Squeeze, Option Prices Hit Record Highs
Create E-mail Alert Related Categories
OptionsRelated Entities
Options
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
